 |
|
|
||||||
|
||||||||
|
|
|||||||
|
||||||||
|
|
Home :: | |||
 A.M. Biobusiness Series ASMR's morning series took an in-depth look at leading-edge advances in biotechnology businesses through presentations by panels of experts whose companies exemplified the successful conversion of innovative scientific exploration into robust commercial value. 4.01.04 | Theranostics This program was dedicated to an emerging trend in clinical development - "pairing a diagnostic with a therapeutic compound based on a common target." Attendees discovered how this can lead to better selection of patient populations for clinical trials and the potential for improved clinical results. Attendees heard how local bioentrepreneurs and their companies were engaged in developing theranostic products, leveraging them into corporate deals and generating early revenues and shareholder value. 2.04.04 | Drug Targets This program was dedicated to one of the greatest bottlenecks in modern pharmaceutical development "qualifying therapeutically relevant drug targets." Attendees learned why this was the case and how several local companies were turning this opportunity into shareholder value. Attendees heard about new strategies to accelerate identification and improve the qualification of targets. Then, they discovered how rapid and efficient structural studies laid the foundation for rational drug design. Attendees met the corporations that are building their futures on technologies designed to address the challenges of drug discovery and development. 11.13.03 | Mining Proteomics This program focused on the enormous challenges of extracting meaningful commercial value from the wealth of proteomic data that was already available and the inundation that will become available in the imminent future. Attendees learned the challenges and opportunities that this information presented to companies and the strategies they were devising to translate it into significant commercial gains. 10.23.03 | Latest Developments in Vaccines & Vaccine Delivery This program was focused on exploring the newest developments in bioinformatics, molecular biology, and immunology that were impacting the design and development of modern vaccines. Attendees heard how these breakthroughs were being combined with novel devices to make delivery safer and more effective. 3.27.03 | Glycomics This program was dedicated to "Glycomics." Attendees learned what it was and how tapping the sophisticated biology of carbohydrates could generate such tremendous commercial opportunities. Beyond both genomics and proteomics; glycomics taps the amazingly dense information capacity of carbohydrates, polysaccharides and glycoconjugates and explains the dazzling recognition specificity of these molecules. The therapeutic opportunities ranged from advanced chiral drug discovery to targeted and/or sustained release drug or gene delivery. The diagnostics applications span from infectious pathogens and tumor markers to personalized medicine. These unique products address important therapeutic areas such as heart disease and inflammation to diabetes and cancer, and beyond to neurological and genetic disorders. Attendees heard from leading local companies and experts on the models for building robust commercial ventures and creating value from uncovering the amazing complexity of glycobiology. 2.06.03 | Splicing This program was dedicated to "Splicing." Attendees learned what it was and how the unraveling of the differences in protein splicing expression patterns between normal and diseased cells and tissue offered such tremendous potential. Attendees heard from leading local companies and experts on the models for building robust commercial ventures and creating value from uncovering this amazing diversity. event sponsors
Gold Sponsors
|
 |
|||
|
 © copyright 2006 ASM Resources Inc. All rights reserved. |